Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,353,641
-$37,768,278 QoQ
Shares Held
257,091
-82.8% QoQ
Ownership
0.883%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. ANAB ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,353,641 | 257,091 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $55,121,919 | 993,905 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $50,155,564 | 1,034,562 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $47,652,539 | 1,556,258 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $41,510,445 | 1,869,840 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $9,381,154 | 504,636 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,858,749 | 215,917 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $5,942,284 | 177,382 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,299,707 | 91,768 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $14,325,252 | 636,114 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $12,895,523 | 602,032 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,454,518 | 80,987 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,456,705 | 71,618 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,146,190 | 98,630 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,972,433 | 95,916 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,744,062 | 107,568 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,977,084 | 146,655 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,597,468 | 104,991 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,527,264 | 72,727 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,951,173 | 71,946 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,192,237 | 161,675 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,438,072 | 159,539 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $463,171 | 21,543 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $109,885 | 7,450 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $433,304 | 19,396 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,122,847 | 504,094 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||